A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Drug Safety

• Publication date

  2017-08-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1007/s40264-017-0579-1PMID 28766108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?

  2017cited by this paper
• Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data Sets

  2016cited by this paper
• Variation in the pharmaceutical costs of New Zealand general practices: a national database linkage study.

  2016cited by this paper
• Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

  2016cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study

  2016cited by this paper
• Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury

  2016cited by this paper
• Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

  2016cited by this paper
• Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study

  2016cited by this paper
• Ethnic differences in case fatality following an acute ischaemic heart disease event in New Zealand: ANZACS-QI 13

  2016cited by this paper
• One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8)

  2015cited by this paper
• Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand.

  2015cited by this paper
• Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study

  2015cited by this paper
• Cardiac risks associated with antibiotics: azithromycin and levofloxacin

  2015cited by this paper
• A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use

  2014influential reference
• Efficiency, effectiveness, equity (E3). Evaluating hospital performance in three dimensions.

  2013cited by this paper
• Ethnic disparities in asthma treatment and outcomes in children aged under 15 years in New Zealand: analysis of national databases

  2013cited by this paper
• Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome.

  2013cited by this paper
• Proton pump inhibitors and acute kidney injury: a nested case–control study

  2013influential reference
• Overview of Pharmacoepidemiological Databases in the Assessment of Medicines Under Real-Life Conditions

  2012cited by this paper
• Azithromycin and the risk of cardiovascular death.

  2012cited by this paper
• Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

  2012cited by this paper
• Acute kidney injury: a guide to diagnosis and management.

  2012cited by this paper
• Proton pump inhibitors and traditional nonsteroidal anti‐inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

  2012influential reference
• Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

  2012cited by this paper
• Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project

  2011cited by this paper
• A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men

  2010cited by this paper
• Semi‐automated risk estimation using large databases: quinolones and clostridium difficile associated diarrhea

  2010cited by this paper
• Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

  2010cited by this paper
• Use of multiple international healthcare databases for the detection of rare drug‐associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins

  2010cited by this paper
• Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

  2010cited by this paper
• Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

  2009cited by this paper
• Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.

  2008influential reference
• Observational Research, Randomised Trials, and Two Views of Medical Science

  2008cited by this paper
• Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies

  2006cited by this paper
• What is the best evidence for determining harms of medical treatment?

  2006cited by this paper
• Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis

  2006cited by this paper
• Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis.

  2006cited by this paper
• Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

  2006cited by this paper
• Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database.

  2004cited by this paper
• Drug induced QT prolongation and torsades de pointes

  2003cited by this paper
• Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.

  2003cited by this paper
• Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

  2001cited by this paper
• Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.

  2000influential reference
• Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study

  1999cited by this paper
• Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• ADAPTING A CLINICAL COMORBIDITY USE WITH ICD-g-CM ADMINISTRATIVE INDEX FOR DATABASES

  1992cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992influential reference

• Leveraging Real-World Data in Safety Signal Assessment

  2024cites this paper
• Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review

  2022cites this paper
• Risk of Gastrointestinal Bleeding with Concurrent Use of NSAID and SSRI: A Systematic Review and Network Meta-Analysis

  2022cites this paper
• Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case–Control Study with a Focus on Medicines Used in Primary Care

  2022cites this paper
• Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study

  2021cites this paper
• Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database

  2020cites this paper
• Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial

  2018cites this paper
• Validation studies of claims data in the Asia‐Pacific region: A comprehensive review

  2018cites this paper
• Understanding medicines with a propensity to increase the risk of heart failure: Combining existing knowledge with targeted population assessment

  2018cites this paper